The 20 Best Malignant Mixed Mullerian Tumor Doctors Near Me in Issaquah, WA

Dr. Wahl is a native of the Pacific Northwest and a perennial winner of the Seattle Met Top Doctor award. Dr. Wahl graduated from the University of Washington with a BS in Technical Communication and attended Duke School of Medicine in Durham, North Carolina. There she received a Stead Scholarship and a Howard Hughes Medical Institute Research Fellowship, studying cell signal transduction in yeast. She completed Internal Medicine Residency and Chief Residency at Stanford University Hospital and Medical Center in Palo Alto, California and returned to Seattle to complete her Hematology Fellowship at University of Washington/Fred Hutchinson Cancer Research Center. Dr. Wahl is Board Certified in Medical Oncology and has been in practice since 2003. She is happy to care for patients with any cancer diagnosis and has a special interest in breast cancer, gynecologic malignancies and clinical research. She particularly enjoys working with patients collaboratively in order to optimize the quality of the care they receive. Dr. Wahl is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Ampullary Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer.

I strive to provide personalized, cutting-edge therapy in a multidisciplinary setting. I offer patients and families understandable knowledge in order for them to navigate the illness and treatment process, and to build true partnerships with compassion, empathy and respect. Dr. Xie is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, and Bone Marrow Aspiration.

David Dong is an Oncologist in Issaquah, Washington. Dr. Dong is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Small Cell Lung Cancer (SCLC), Angiosarcoma, Pleuropulmonary Blastoma, and Lung Cancer.

Nancy Sharma is an Oncologist in Issaquah, Washington. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Familial Colorectal Cancer, Breast Cancer, Paget Disease of the Breast, and Colorectal Cancer.

Jason Lukas is an Oncologist in Issaquah, Washington. Dr. Lukas is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Familial Colorectal Cancer.

Dr. Drescher is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Drescher’s goal is to provide the absolute best care for each and every patient. Potential treatment options are large and ever increasing. He works hard to ensure patients are aware and understand all options available to them and then work together to identify the optimal approach. Dr. Drescher listens carefully and works closely with a team of providers to ensure problems are addressed in a holistic way. Dr. Drescher is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Ovarian Cancer, Malignant Mixed Mullerian Tumor, Endometrial Cancer, Oophorectomy, and Salpingo-Oophorectomy.

Dr. BonDurant is a multiple-time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. BonDurant believes what makes a great physician is not only skill, but the ability to genuinely care about patients. To be this type of physician every day, she strives to provide innovative quality medicine with sincere appreciation, compassion and respect for her patients. It's her privilege to care for such strong and courageous women during difficult times in their lives. Dr. Bondurant is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Malignant Mixed Mullerian Tumor, Ovarian Cancer, Endometrial Cancer, Oophorectomy, and Hernia Surgery.

Dr. Dan Veljovich is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. With an attention to respecting autonomy, calming fears and partnering with patients to help them make treatment decisions in line with their own goals, Dr. Veljovich embodies compassionate care. He feels blessed to be able to help women maintain their dignity and preserve their quality of life while undergoing surgical or medical treatments. Dr. Veljovich is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Ovarian Cancer, Malignant Mixed Mullerian Tumor, Testicular Yolk Sac Tumor, Oophorectomy, and Hernia Surgery.

Dr. Shah is a multiple time recipient of the Seattle Magazine and Seattle Metropolitan Magazine Top Doctor Award including the Seattle Metropolitan Best of the Best Top Doctor Designation. Dr. Shah endeavors to provide comprehensive, thoughtful and dedicated level of care to women with or at risk for gynecologic cancers and their families. As a gynecologic oncologist, he is in the unique position of being able to provide comprehensive, personalized care. Whether a condition calls for surgery, chemotherapy or radiation treatment, Dr. Shah aims to be the primary care provider for a woman’s oncologic concerns. Having completed training in advanced surgical techniques (including robotic surgery), radical abdominal procedures and cutting-edge research, his goal is to treat his patients with the most current, effective and state-of-the-art treatment options available. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Malignant Mixed Mullerian Tumor, Ovarian Cancer, Endometrial Cancer, Oophorectomy, and Hysterectomy.

Dr. Musa is a multiple-time recipient of the Seattle Top Doctor Award and most recently received the 2023 Seattle Met Top Doc Award. Dr. Musa prides herself in taking care of her patients as a whole. She is happy to offer them minimally invasive surgery whenever possible and feels privileged to also be able to care for them throughout their treatment. Dr. Musa is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Malignant Mixed Mullerian Tumor, Sertoli-Leydig Cell Tumor, Ovarian Cancer, Hysterectomy, and Oophorectomy.

Dr. Press is a Seattle Top Doc Award Winner and most recently received the 2023 Seattle Met Top Doc Award for Gynecologic Oncology. Dr. Press' aim is to be a leader in providing thorough, innovative, and compassionate care for women with or who are at-risk for gynecologic cancers, and those with other complicated benign conditions. He uses the most current techniques and treatments available, such as aggressive radical surgery, precise minimally invasive/robotic surgery, or complex medical care with chemotherapy as part of patient care. Dr. Press also believes that treatment involves providing an environment that promotes respect, positive communication, and collaboration among all healthcare and family members. Dr. Press is dedicated to meeting the unique and diverse needs of his patients, and committed to excellence in evidence-based practice, research, and professional development. Dr. Press is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Vulvar Cancer, Bladder Reconstruction, and Hysterectomy.

Amy Brockmeyer, MD, is a board-certified gynecologic oncologist who specializes in the surgical and medical management of ovarian, endometrial and cervical cancer. Dr. Brockmeyer has expertise in minimally invasive surgery including laparoscopic and robotic surgery, and complex pelvic surgery. She has additional board certification in hospice and palliative care which allows her to provide the best evidence-based symptom management when needed. She is an expert in chemotherapy administration for gynecologic cancer.Dr. Brockmeyer values patient education and shared decision making when planning for surgery or medical management of each diagnosis.Outside of Virginia Mason, Dr. Brockmeyer enjoys running, traveling, and spending time with her family and friends. Dr. Brockmeyer is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Endometrial Cancer, Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Bladder Reconstruction, and Hysterectomy.

Ron Swensen is an Oncologist in Renton, Washington. Dr. Swensen is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Endometrial Stromal Sarcoma, Oophorectomy, and Bladder Reconstruction.

Dr. Hastings is committed to providing comprehensive care for women throughout their lifetime. Having completed a fellowship year in female pelvic medicine and gynecologic surgery, she has a particular interest in medical and surgical management of common gynecologic problems including endometriosis and abnormal uterine bleeding. Outside of work, Dr. Hastings enjoys staying active trying fitness classes all over Seattle, cooking, traveling, and spending time with her family. Dr. Hastings is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Cervical Dysplasia.

"Dr. Fengting Yan is a 2021, 2022, & 2023 Seattle Met Top Doctor Award winner. Dr. Yan is interested in personalized care and translational research in women’s cancer. Extensive lab and clinical research knowledge are applied in her ""bench-to-bedside"" approach to patient care. Dr. Yan also has years of experience in public education on women’s health through internet and TV talk shows.". Dr. Yan is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Breast Cancer in Men, and Inflammatory Breast Cancer.

Swathi Namburi, MD, is a hematologist who specializes in treating a variety of blood cancer and blood disorders. Her clinical research interests include multiple myeloma and novel immunotherapy approaches for blood cancers. Dr. Namburi is part of the Center for Blood Disorders and Cellular Therapy at the Swedish Cancer Institute. She provides full-spectrum care for her patients. This includes initial consultation and diagnosis, treatment to help achieve remission, consideration and enrollment onto clinical trials open through Providence/Swedish health care, and long-term management and survivorship related care. She oversees her patients through CAR-T cell therapy and autologous stem cell transplantation as these needs come up during various phases of treatment. Dr. Namburi completed a fellowship in hematology/oncology at the University of Pittsburgh Medical Center. She completed her residency at the George Washington University Medical Center in DC, and prior to that attended medical school at Rutgers/UMDNJ in New Brunswick, NJ near to where she grew up in East Brunswick, NJ. She is board certified in internal medicine, medical oncology, and hematology. She can communicate in several languages including Telugu, Hindi, Spanish, and French and she liberally receives help from Swedish’s wonderful in-person medical translators. Dr. Namburi has been practicing in the Seattle-Tacoma region since 2018. She is a board member of the Washington State Medical Oncology Society and participates in the annual Washington State Medical Association meetings to help support state initiatives that will help our patients with cancer have access to excellent care and treatment. She regularly attends and presents her work at national and international hematology conferences. Dr. Namburi is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Multiple Myeloma, Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.

I listen to and address the concerns of my patients and their family members and involve them in treatment decisions through education and discussion. Dr. Dabhi's medical interests include: gastrointestinal (esophageal, stomach, colon, rectal) hematologic cancers (lymphoma, leukemia) and breast cancer. Dr. Dabhi is a Clinical Instructor in the Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine. Dr. Dabhi is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Splenomegaly, Pleuropulmonary Blastoma, Lung Cancer, and Small Cell Lung Cancer (SCLC).

Joshua Wilfong is a Hematologist and an Oncologist in Bellevue, Washington. Dr. Wilfong has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Non-Hodgkin Lymphoma, and Gastric Lymphoma.

Naixi Chen is an Oncologist in Renton, Washington. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Scurvy, and Muscle Invasive Bladder Cancer.

Michelle Zhang is an Oncologist in Renton, Washington. Dr. Zhang is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. Her top areas of expertise are Paget Disease of the Breast, Anal Cancer, Inflammatory Breast Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.